RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000083.xml
Synlett 2006(18): 2969-2972
DOI: 10.1055/s-2006-941583
DOI: 10.1055/s-2006-941583
LETTER
© Georg Thieme Verlag Stuttgart · New YorkPalladium-Catalyzed Alkylation-Alkenylation Reactions: Rapid Access to Tricyclic Mescaline Analogues
Weitere Informationen
Received
16 February 2006
Publikationsdatum:
29. Juni 2006 (online)
Publikationsverlauf
Publikationsdatum:
29. Juni 2006 (online)

Abstract
A norbornene-mediated palladium-catalyzed sequence is described in which two alkyl-aryl bonds and one alkenyl-aryl bond are formed in one pot. A variety of symmetrical and unsymmetrical tricyclic heterocycles were synthesized in good yields from a Heck acceptor and an aryl iodide containing two tethered alkyl bromides. This methodology was applied to the synthesis of a tricyclic mescaline analogue.
Key words
palladium - annulations - Heck reaction - mescaline - microwave irradiation
- 1a
Tietze LF.Beifuss U. Angew. Chem., Int. Ed. Engl. 1993, 32: 131 - 1b
Tietze LF. Chem. Rev. 1996, 96: 115 - 1c
Denmark SE.Thorarensen A. Chem. Rev. 1996, 96: 137 - 1d
Tietze LF.Rackelmann N. Pure Appl. Chem. 2004, 76: 1967 - 2a
Grigg R.Sridharan V. J. Organomet. Chem. 1999, 576: 65 - 2b
de Meijere A.Bräse S. J. Organomet. Chem. 1999, 576: 88 - 2c
Larock RC. J. Organomet. Chem. 1999, 576: 111 - 2d
Yet L. Chem. Rev. 2000, 100: 2963 - 2e
Poli G.Giambastini G.Heumann A. Tetrahedron 2000, 56: 5959 - 2f
Cacchi S.Fabrizi G.Goggiomani A. Heterocycles 2002, 56: 613 - 2g
Cacchi S.Fabrizi G.Parisi LM. Heterocycles 2002, 58: 667 - 2h
Battistuzzi G.Cacchi S.Fabrizi G. Eur. J. Org. Chem. 2002, 2671 - 3a
Catellani M.Frignani F.Rangoni A. Angew. Chem., Int. Ed. Engl. 1997, 36: 119 - 3b
Catellani M.Mealli C.Motti E.Paoli P.Perez-Carreño E.Pregosin PS. J. Am. Chem. Soc. 2002, 124: 4336 - 3c
Catellani M. Synlett 2003, 298 - 3d
Catellani M. Top. Organomet. Chem. 2005, 14: 21 - 4a
Lautens M.Piguel S. Angew. Chem. Int. Ed. 2000, 39: 1045 - 4b
Lautens M.Paquin J.-F.Piguel S.Dahlmann M. J. Org. Chem. 2001, 66: 8127 - 4c
Lautens M.Paquin J.-F.Piguel S. J. Org. Chem. 2002, 67: 3972 - 4d
Alberico D.Paquin J.-F.Lautens M. Tetrahedron 2005, 61: 6283 - 4e
Bressy C.Alberico D.Lautens M. J. Am. Chem. Soc. 2005, 127: 13148 - 5
Pache S.Lautens M. Org. Lett. 2003, 5: 4827 - 6
Monte AP.Waldman SR.Marona-Lewicka D.Wainscott DB.Nelson DL.Sanders-Bush E.Nichols DE. J. Med. Chem. 1997, 40: 2997 - 7a
Huang K.-S.Lin M.Yu L.-N.Kong M. Tetrahedron 2000, 56: 1321 - 7b
Chambers JJ.Kurrasch-Orbaugh DM.Nichols DE. Bioorg. Med. Chem. Lett. 2002, 12: 1997 - 8a
Lindstrom P.Tierney J.Wathey B.Westman J. Tetrahedron 2001, 57: 9225 - 8b
Larhed M.Moberg C.Hallberg A. Acc. Chem. Res. 2002, 35: 717 - 9
Willans CE.Mulders JMCA.de Vries JG.de Vries AHM. J. Organomet. Chem. 2003, 687: 494 ; and references cited therein - 10a
Ahrendt KA.Bergman RG.Ellman JA. Org. Lett. 2003, 5: 1301 - 10b
Thalji RK.Ahrendt KA.Bergman RG.Ellman JA. J. Org. Chem. 2005, 70: 6775 - 11
Kapadia GJ.Fayez MBE. J. Pharm. Sci. 1970, 59: 1699 - 12a
Nichols DE.Glennon RA. In Hallucinogens: Neurochemical, Behavioral, and Clinical PerspectivesJacobs BL. Raven Press; New York: 1984. p.95-142 - 12b
Nichols DE. In Amphetamine and Its AnaloguesCho AK.Segal DS. Academic Press; San Diego CA: 1994. p.3-41 - 12c
Nichols DE. Pharmacol. Ther. 2004, 101: 131 - 13a
Glennon RA.Titeler M.McKenney JD. Life Sci. 1984, 35: 2502 - 13b
Rasmussen K.Aghajanian GK.
Brain Res. 1986, 385: 395 - 13c
Titeler M.Lyon RA.Glennon RA. Psychopharmacology 1988, 94: 213 - 13d
Appel JB.Callahan PM. Eur. J. Pharmacol. 1989, 159: 41 - 13e
Aghajanian GK.Marek GJ. Neuropsychopharmacology 1999, 21: 16S - 13f
Aghajanian GK.Marek G. J. Brain Res. Rev. 2000, 31: 302 - 14
Green K. J. Org. Chem. 1991, 56: 4325 - 15
Gómez-Sánchez E.Marco-Contelles J. Tetrahedron 2005, 61: 1207